Ataluren
Duchenne muscular dystrophy medication / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Ataluren?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy. It was designed by PTC Therapeutics.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Translarna |
Other names | PTC124 |
AHFS/Drugs.com | International Drug Names |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.132.097 |
Chemical and physical data | |
Formula | C15H9FN2O3 |
Molar mass | 284.246 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) |
Close